PrimeBioMed
2013
FOUNDED
PRIVATE
STATUS
Early Stage VC
LATEST DEAL TYPE
2
INVESTORS
Description
Provider of an innovative diagnostic systems intended to develop antibodies for cancer diagnosis. The company's systems includes development and manufacture of antibodies, enabling clients to treat cancer easily.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- Naychny proezd 20
- b. 3
- Moscow, 117246
- Russia
+7 8 (000) 000-00-00
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore PrimeBioMed’s full profile, request a free trial.
PrimeBioMed Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC | 25-Sep-2017 | 00.000 | Completed | Generating Revenue | ||
| 2. Early Stage VC | 00.000 | Completed | Generating Revenue | |||
| 1. Early Stage VC (Series A) | 01-Jan-2013 | $2.02M | $2.02M | Completed | Generating Revenue |
PrimeBioMed Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Russian Venture Company | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Skolkovo Foundation | Limited Partner | Minority | 000 0000 | 000000 0 |